<h2 id="what-is-dexamethasone">What is Dexamethasone?</h2>
<ul>
  <li>Dexamethasone is a glucocorticoid used in the perioperative period for [[Post-operative Nausea and Vomiting]] and airway swelling.</li>
</ul>
<h2 id="mechanism-of-action-">Mechanism of Action <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li>Dexamethasone binds to intracellular glucocorticoid receptors inhibiting inflammatory mediators.</li>
  <li>Inhibits prostaglandin synthesis and causes antiemetic effect.</li>
</ul>
<h2 id="indications-">Indications <sup id="fnref:1:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2:1" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li><strong>Antiemetic:</strong> Prevention and treatment of [[Post-operative Nausea and Vomiting]] (PONV).</li>
  <li><strong>Anti-inflammatory:</strong> Often used in ENT and airway surgery to reduce the risk of swelling.</li>
  <li><strong>Cerebral Edema:</strong> Reduction of intracranial pressure, generally reserved for brain tumors</li>
</ul>
<h2 id="dosage-">Dosage <sup id="fnref:2:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li><strong>PONV:</strong> 0.1 mg/kg IV up to 4-6 mg <sup id="fnref:2:3" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></li>
  <li><strong>Inflammatory:</strong> Dose depends on clinical scenario, but 0.1-0.2 mg/kg up to ~10mg is common.</li>
</ul>
<h2 id="pharmacokinetics-">Pharmacokinetics <sup id="fnref:1:2" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li><strong>Onset of Action:</strong> 2-4 hours</li>
  <li><strong>Half-life:</strong> 36-54 hours.</li>
  <li><strong>Metabolism:</strong> Hepatic</li>
  <li><strong>Excretion:</strong> Metabolites are primarily excreted in the urine.</li>
</ul>
<h2 id="complications-">Complications <sup id="fnref:2:4" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li><strong>Hyperglycemia</strong></li>
  <li><strong>Adrenal Suppression:</strong> Generally risk increases with prolonged use.</li>
  <li><strong>Perineal Pain:</strong> Rapid injection in awake patients often results in perineal pain.</li>
</ul>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>Birdi T, Sullivan P. <em>Ottawa anesthesia primer</em>. Toronto, Ontario: Echo Book Publishing; 2012. <a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:1:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:1:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a></p>
    </li>
    <li id="fn:2" role="doc-endnote">
      <p>Gan TJ, Belani KG, Bergese S, et al. <em>Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting</em>. Anesth Analg. 2020. <a href="#fnref:2" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:2:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:2:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:2:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a> <a href="#fnref:2:4" class="reversefootnote" role="doc-backlink">&#8617;<sup>5</sup></a></p>
    </li>
  </ol>
</div>